Review article: Cost-effectiveness of different GERD management strategies

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 4, 2002, Pages 79-82

  Vakil, N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; GENERIC DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; ANTIULCER AGENT;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMICS; ENTEROPATHY; ESOPHAGITIS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INTESTINE MUCOSA; LONG TERM CARE; MAINTENANCE THERAPY; MEDICAL PRACTICE; OUTPATIENT CARE; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; DRUG ADMINISTRATION; HEALTH CARE COST; UNITED STATES;

ANTI-ULCER AGENTS; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HUMAN; UNITED STATES; HUMANS;

EID: 0036654669     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Costs of acid reflux disorders to a health maintenance organization
2. Utilisation and expenditures in the treatment of patients with gastroesophageal reflux disease
3. Measuring lost productivity in patients with gastro-oesophageal reflux disease using a productivity questionnaire (WPAI-GORD)
4. Cost and quality effects of alternative treatments for persistent GERD
5. Quality of life and cost of therapy in reflux disease
6. Economic evaluation of long term management strategies for erosive oesophagitis
7. In Finland, Sweden and the UK, esomeprazole is cost-effective compared with omeprazole for the acute treatment of patients with reflux esophagitis
8. Proton pump inhibitors versus H2 receptor antagonists for the treatment of erosive gastroesophageal reflux disease. A cost-comparative study
9. Economic analysis of step-wise treatment of gastro-esophageal reflux disease
10. Step-down management of gastro-esophageal reflux disease
11. Management of heartburn in a large, randomized, community-based study: Comparison of 4 therapeutic strategies
12. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary clinics in West Virginia
13. Are patients carrying the burden of managed care cost control measures
14. Symptomatic gastro-esophageal reflux disease: Double blind controlled study of intermittent treatment with omeprazole or ranitidine
15. Cost-effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic GERD
16. Long-term prescribing of proton pump inhibitors in general practice
17. On demand therapy with omeprazole for the long-term management of patients with heartburn without esophagitis - A placebo-controlled randomized trial
18. Esomeprazole 20 mg maintains symptom control in endoscopy-negative GERD. A randomized placebo-controlled trial of on-demand therapy for 6 months